Staff Bio
Darin S. Carroll, PhD
Division of Core Laboratory Services and Response
Darin S. Carroll, PhD, is the director of the Division of Core Laboratory Services & Response in CDC’s National Center for Emerging and Zoonotic Infectious Diseases.
Role at CDC
Dr. Carrol is the director of NCEZID's Division of Core Laboratory Services & Response (DCLSR). As director of DCLSR, Dr. Carroll helps DCLSR meet their mission of using cutting edge technology to produce high quality products and services to support the public health efforts of CDC laboratorians and CDC's emergency preparedness and response activities.
Dr. Carroll joined CDC in 2002 as a member of the Viral Special Pathogens Branch in NCEZID's Division of Viral and Rickettsial Diseases. He accepted an assignment to the Poxvirus Team during a 2003 U.S. outbreak of mpox (then known as monkeypox) and led investigations in Ghana to understand the origins of the 2003 U.S. outbreak. In 2008, Dr. Carroll became the Poxvirus Team's Ecology and Animal Studies Unit Lead, and in that capacity participated and led field investigations on mpox (Republic of the Congo and Democratic Republic of the Congo) and tana pox (Kenya) and became the DHCPP Poxvirus and Rabies Branch chief in 2014.
Dr. Carroll previously served as NCEZID's deputy associate director for infectious disease preparedness. In this capacity, he helped provide senior-level oversight and coordination for NCEZID's portfolio on global health, domestic preparedness and response, and the One Health Office.
Additional roles he held at NCEZID include acting senior advisor for laboratory science to the deputy director for infectious diseases; deputy director for infectious diseases; and chief of the Poxvirus and Rabies Branch in the Division of High-Consequence Pathogens and Pathology. He also served as the director of the Occupational Health and Safety Office in the Office of Safety, Security, and Asset Management at CDC.
Achievements
Dr. Carroll has more than 18 years of experience in organizing and participating in domestic and international outbreak field and laboratory operations involving investigations of emerging viral zoonotic diseases in over 11 developing countries. He has more than 10 years of direct laboratory leadership experience with laboratory assay development and quality control, CLIA guidelines, select agent regulations compliance, pharmaceutical development, and multiple advanced molecular detection techniques, and has organized and led in vitro and in vivo studies in Biological Safety Levels 2–4. He has current and past collaborations with FDA, NIH, USDA, BARDA, ASPR, DoD, and HHS.